NCT04635410

Brief Summary

The progress of labour is traditionally determined by regular vaginal examinations (VEs) to assess the cervix (neck of the womb) and the baby's head position. Such examinations can be uncomfortable and risk causing infection to the baby or mother's womb. The findings are subjective, can be unreliable and cannot be recorded for later review and analysis. The novel, non-intrusive "transperineal ultrasound" technique has been developed utilising existing scanning machines normally found on a delivery unit, with the ultrasound probe placed outside the woman's vagina. This allows objective, recordable measurements creating images that can be captured and stored electronically. This is a prospective longitudinal observational cohort study in nulliparous term (37-42 weeks) labouring women. This study aims to improve the prediction of intrapartum Caesarean Delivery (ICD). The study contains ultrasound and clinical assessments: Transabdominal Ultrasound to measure: Umbilical and Middle Cerebral Artery Doppler, fetal head position and Amniotic Fluid Index (AFI). Transperineal Ultrasound to assess: Head Perineum Distance (HPD), Caput Succedaneum and moulding. Digital vaginal examination by a caregiver: to measure cervical dilatation. Primary outcome:

  • Mode of delivery Secondary outcome:
  • Time to delivery Neonatal outcomes:
  • Apgar score, cord pH level, gender, fetal birth weight, neonatal unit admission within 24 hours, neonatal morbidity.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 3, 2020

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

November 12, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 19, 2020

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

September 5, 2021

Status Verified

September 1, 2021

Enrollment Period

5 years

First QC Date

November 12, 2020

Last Update Submit

September 1, 2021

Conditions

Keywords

NO CONDITIONS

Outcome Measures

Primary Outcomes (1)

  • Intrapartum Caesarean delivery (ICD)

    Number of participants who delivered by Caesarean section

    3 years

Secondary Outcomes (1)

  • Time to delivery (length of labour of onset of the first stage to the completion of the second stage).

    12-24 hours

Interventions

SCAN LABOURING WOMEN BY ULTRASOUND

Eligibility Criteria

Age18 Years - 44 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsLABOURING WOMEN
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Recruitment will start upon approval of the study. The infrastructure, research fellow, ultrasound machines, and the database are already in place, which ensure that the study can start promptly upon approval, without affecting or compromising routine clinical service provision. We aim to recruit minimum number according to the following calculations: In the labour prediction model, there are approximately 12 variables with 10 patients needed per variable and an approximate 25% Caesarean section rate (the primary outcome) in the UK currently. Practical calculation: 12 x 10 x (100/25) = 480 patients For predictive modelling, 480 patients minimum are required (37- 42 weeks). We have recruited 269 patients in the previous study, therefore, approximately 211 fully evaluable patients will be needed. We intend to recruit 240 participants to allow approximately 10% incomplete data/study withdrawals

You may qualify if:

  • Aged 18-44.
  • Cephalic presentation.
  • Nulliparous.
  • Singleton.

You may not qualify if:

  • Younger than 18 years.
  • Life-threatening maternal or fetal compromise needing immediate medical attention and/or delivery.
  • Women who in the opinion of the researcher are unable to give fully informed consent to the study.
  • Non-cephalic presentations.
  • Multiple pregnancies.
  • Multiparous patients.
  • Not in established labour

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Imperial college NHS Trust Queen Charlotte and Chelsea Hospital

London, United Kingdom

RECRUITING

MeSH Terms

Interventions

High-Energy Shock Waves

Intervention Hierarchy (Ancestors)

Ultrasonic WavesSoundRadiation, NonionizingRadiationPhysical Phenomena

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Month
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 12, 2020

First Posted

November 19, 2020

Study Start

February 3, 2020

Primary Completion

February 1, 2025

Study Completion

February 1, 2025

Last Updated

September 5, 2021

Record last verified: 2021-09

Locations